Lithium Resistance in Bipolar Tied to Deficient Gene Expression



A decrease in activation of the LEF1 gene may be the reason why many patients with bipolar disorder do not respond to lithium, considered the ‘gold standard’ treatment, new research suggests.
Medscape Medical News

Source link

Comments are closed, but trackbacks and pingbacks are open.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy